NURPF
Price
$8.81
Change
-$0.05 (-0.56%)
Updated
Jun 16 closing price
Capitalization
1.17B
TCRT
Price
$5.13
Change
+$0.11 (+2.19%)
Updated
Jun 27 closing price
Capitalization
8.41M
Interact to see
Advertisement

NURPF vs TCRT

Header iconNURPF vs TCRT Comparison
Open Charts NURPF vs TCRTBanner chart's image
Neuren Pharmaceuticals
Price$8.81
Change-$0.05 (-0.56%)
Volume$375
Capitalization1.17B
Alaunos Therapeutics
Price$5.13
Change+$0.11 (+2.19%)
Volume$40.99K
Capitalization8.41M
NURPF vs TCRT Comparison Chart in %
Loading...
NURPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NURPF vs. TCRT commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NURPF is a Hold and TCRT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (NURPF: $8.81 vs. TCRT: $5.13)
Brand notoriety: NURPF and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NURPF: 28% vs. TCRT: 135%
Market capitalization -- NURPF: $1.17B vs. TCRT: $8.41M
NURPF [@Biotechnology] is valued at $1.17B. TCRT’s [@Biotechnology] market capitalization is $8.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NURPF’s FA Score shows that 0 FA rating(s) are green whileTCRT’s FA Score has 0 green FA rating(s).

  • NURPF’s FA Score: 0 green, 5 red.
  • TCRT’s FA Score: 0 green, 5 red.
According to our system of comparison, NURPF is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NURPF’s TA Score shows that 2 TA indicator(s) are bullish while TCRT’s TA Score has 4 bullish TA indicator(s).

  • NURPF’s TA Score: 2 bullish, 4 bearish.
  • TCRT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TCRT is a better buy in the short-term than NURPF.

Price Growth

NURPF (@Biotechnology) experienced а 0.00% price change this week, while TCRT (@Biotechnology) price change was +19.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NURPF($1.17B) has a higher market cap than TCRT($8.41M). TCRT YTD gains are higher at: 169.291 vs. NURPF (16.380).
NURPFTCRTNURPF / TCRT
Capitalization1.17B8.41M13,922%
EBITDAN/A-4.03M-
Gain YTD16.380169.29110%
P/E Ratio12.44N/A-
RevenueN/A11K-
Total CashN/A319K-
Total DebtN/A0-
FUNDAMENTALS RATINGS
NURPF vs TCRT: Fundamental Ratings
NURPF
TCRT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
51100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4834
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NURPF's Valuation (70) in the null industry is in the same range as TCRT (81) in the Biotechnology industry. This means that NURPF’s stock grew similarly to TCRT’s over the last 12 months.

NURPF's Profit vs Risk Rating (51) in the null industry is somewhat better than the same rating for TCRT (100) in the Biotechnology industry. This means that NURPF’s stock grew somewhat faster than TCRT’s over the last 12 months.

NURPF's SMR Rating (95) in the null industry is in the same range as TCRT (99) in the Biotechnology industry. This means that NURPF’s stock grew similarly to TCRT’s over the last 12 months.

TCRT's Price Growth Rating (34) in the Biotechnology industry is in the same range as NURPF (48) in the null industry. This means that TCRT’s stock grew similarly to NURPF’s over the last 12 months.

NURPF's P/E Growth Rating (84) in the null industry is in the same range as TCRT (100) in the Biotechnology industry. This means that NURPF’s stock grew similarly to TCRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NURPFTCRT
RSI
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NURPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRVX47.880.56
+1.18%
MFS International Growth R4
ERLGX19.200.09
+0.47%
Eaton Vance Atlanta Capital Fcs Gr R6
WWSCX16.170.02
+0.12%
Keeley Small Cap Fund C
SVUIX38.520.04
+0.10%
NAA SMid Cap Value Institutional
OGMNX34.17-1.32
-3.72%
Invesco Gold & Special Minerals R

NURPF and

Correlation & Price change

A.I.dvisor tells us that NURPF and ASPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NURPF and ASPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURPF
1D Price
Change %
NURPF100%
N/A
ASPHF - NURPF
30%
Poorly correlated
N/A
TCRT - NURPF
24%
Poorly correlated
+2.19%
IMAB - NURPF
23%
Poorly correlated
+27.23%
CLSD - NURPF
23%
Poorly correlated
-5.06%
SRZN - NURPF
22%
Poorly correlated
+8.02%
More

TCRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with GLTO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
+2.19%
GLTO - TCRT
56%
Loosely correlated
-2.29%
DSGN - TCRT
56%
Loosely correlated
-6.54%
BTAI - TCRT
26%
Poorly correlated
-13.66%
ADAP - TCRT
25%
Poorly correlated
+1.16%
RVPH - TCRT
25%
Poorly correlated
-5.73%
More